Lithera, Inc., a clinical stage pharmaceutical company focused on lifestyle and medical indications in aesthetic medicine and ophthalmology, recently announced the appointment of Lincoln Krochmal, M.D., as chief medical officer. Dr. Krochmal is a board-certified dermatologist and an authority on the development and commercialization of products for the dermatology and aesthetics markets.
New Advances in Treating Hyperpigmentation
This past decade has seen an enormous surge in popularity of skin brightening products formulated specifically to treat hyperpigmentation and…

0 Comments